Fresenius Kabi Oncology Limited Docetaxel Export Data — India (DGFT 2022–2026)

Name: Fresenius Kabi Oncology Limited Docetaxel Export Records India — #1 Exporter, 356 Shipments, $8.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Docetaxel

India Pharmaceutical Trade Intelligence

$39.6M253 Suppliers120 CountriesHS 30049044

ExportsIndia → UNITED STATES26.6%India → AFGHANISTAN10.1%

ImportsGERMANY → India$266.0K SINGAPORE → India$165.7K

#1 Supplier: FRESENIUS KABI #1 Buyer: MYLAN INSTITUTIONAL

Fresenius Kabi Oncology Limited — Docetaxel Exporter #1 | $8.4M Trade Value | TransData Nexus | TransData Nexus

Fresenius Kabi Oncology Limited — Docetaxel Exporter Profile

Indian Pharmaceutical Exporter · #1 for Docetaxel · $8.4M export value · DGFT Verified

Fresenius Kabi Oncology Limited is the #1 Indian exporter of Docetaxel with $8.4M in export value and 356 verified shipments. Fresenius Kabi Oncology Limited holds a 21.1% market share in Docetaxel exports across 21 countries. The company exports 16 pharmaceutical products worth $117.2M across 3 therapeutic categories.

Fresenius Kabi Oncology Limited — Docetaxel Export Profile: Buyers & Destinations

Fresenius Kabi Oncology Limited Docetaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Fresenius Kabi Oncology Limited Export Docetaxel?

Country	Value	Shipments	Share
GERMANY	$2.4M	144	35.1%
COLOMBIA	$961.2K	30	14.2%
THAILAND	$871.0K	26	12.9%
CHILE	$583.9K	15	8.6%

Who Are the Top Buyers of Docetaxel from Fresenius Kabi Oncology Limited?

Buyer	Country	Value	Orders
FRESENIUS KABI DEUTSCHLAND GMBH	GERMANY	$2.4M	144
FRESENIUS KABI COLOMBIA SAS	COLOMBIA	$917.3K	28
FRESENIUS KABI MALAYSIA SDN BHD	MALAYSIA	$402.1K	18
FRESENIUS KABI CHILE LTDA.	CHILE	$375.1K	10
FRESENIUS KABI (THAILAND) LTD	THAILAND	$319.5K	9
FRESENIUS KABI THAILAND LTD	THAILAND	$169.8K	6
ATCO PHARMA INTERNATIONAL PVT LTD	PAKISTAN	$163.0K	8
FRESENIUS KABI MEXICO, S.A. DE C.V.	MEXICO	$161.5K	6
FRESENIUS KABI CHILE LTDA	CHILE	$120.7K	3
FRESENIUS KABI SOUTH AFRICA PTY	SOUTH AFRICA	$100.0K	2

Fresenius Kabi Oncology Limited supplies Docetaxel to 64 buyers globally. The largest buyer is FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), followed by FRESENIUS KABI COLOMBIA SAS (COLOMBIA) and FRESENIUS KABI MALAYSIA SDN BHD (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Docetaxel Formulations Does Fresenius Kabi Oncology Limited Export?

Product Description / Formulation	Value	Shipments
DOCETAXEL KABI INJECTION 80MG/4ML VIAL B	$189.7K	11
DAXOTEL (DOCETAXEL) INJ. USP 120MG/6ML V	$172.2K	4
DAXOTEL (DOCETAXEL ) INJ. 80MG/4ML VIAL	$143.0K	3
DOCETAXEL INJECTION 80MG/4ML VIAL BATCH	$110.9K	3
DOCETAXEL KABI INJ. 160MG/8ML VIAL,BATC	$110.1K	5
DOCETAXEL INJ 20MG 1ML VIAL BATCH NO 87250114AA MFG DT 04 2025 EXP DT 03 2027 5963 VIALS	$102.9K	3
DOCETAXEL INJ. 120MG/6ML VIAL BATCH NO.	$100.0K	2
DOCETAXEL INJ 120MG 6ML VIAL BATCH NO 87230027BB MFG DT 01 2023 EXP DT 12 2024	$100.0K	2
DAXOTEL (DOCETAXEL) INJ. 80MG/4ML VIAL	$100.0K	2
DOCETAXEL INJ 80MG/4ML VIAL BATCH NO.87240485BA, MFG. DT. 11/2024, EXP. DT. 10/2026	$100.0K	2

Fresenius Kabi Oncology Limited exports 286 distinct Docetaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOCETAXEL KABI INJECTION 80MG/4ML VIAL B with 11 shipments worth $189.7K.

How Does Fresenius Kabi Oncology Limited Compare to Nearest Docetaxel Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	FRESENIUS KABI ONCOLOGY LIMITED ★	$8.4M	356	21	$23.5K
2	MYLAN LABORATORIES LIMITED	$3.5M	69	1	$50.0K
4	INTAS PHARMACEUTICALS LIMITED	$2.2M	44	9	$50.0K

Fresenius Kabi Oncology Limited ranks #1 among 253 Indian Docetaxel exporters. Average shipment value of $23.5K compared to the market average of $88.6K. The closest competitors by value are MYLAN LABORATORIES LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Docetaxel Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	530	20.1%
DELHI AIR	416	15.8%
SAHAR AIR CARGO ACC (INBOM4)	379	14.4%
SAHAR AIR	372	14.1%
Bombay Air	132	5.0%
Delhi Air	90	3.4%
HYDERABAD AIR	79	3.0%
HYDERABAD ACC (INHYD4)	54	2.1%

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Docetaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like FKOL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased freight charges and extended transit times, posing significant risks to time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs on Chinese goods, including pharmaceuticals, prompting American importers to seek alternative suppliers. This shift has benefited Indian exporters, as evidenced by the U.S. accounting for approximately 34.5% of India's pharma exports, valued at around $10.5 billion. (actizaindustry.com) However, the U.S. administration's fluctuating tariff policies, including threats of increased tariffs on pharmaceutical imports, necessitate vigilance and adaptability from exporters like FKOL. (lemonde.fr)

In the European Union, regulatory changes such as the Falsified Medicines Directive (FMD) impose stringent requirements on pharmaceutical imports. Compliance with these regulations demands significant investment in serialization and traceability systems. For FKOL, ensuring adherence to such standards is crucial to maintaining access to the lucrative EU market and upholding its reputation for quality and reliability.

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the FDA and WHO emphasizing Good Manufacturing Practices (GMP) compliance. Indian exporters, including FKOL, must navigate this evolving landscape to sustain their market positions. Notably, the FDA has increased inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to escalate this number in 2024. (fact.net.in)

FKOL's commitment to quality is evident in its state-of-the-art Research & Development center in Gurgaon, India. The facility focuses on developing next-generation cytotoxic and cytostatic therapies, ensuring that products meet the highest quality standards irrespective of the target market. (fresenius-kabi-oncology.com) This proactive approach to quality assurance positions FKOL favorably in a competitive and regulated global market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Docetaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Fresenius Kabi Oncology Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 366 individual customs records matching Fresenius Kabi Oncology Limited exporting Docetaxel, covering 286 formulations to 24 countries via 64 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 120+ countries, 641+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Docetaxel

Docetaxel

Fresenius Kabi Oncology Limited — Docetaxel Exporter Profile

Fresenius Kabi Oncology Limited — Docetaxel Export Profile: Buyers & Destinations

Where Does Fresenius Kabi Oncology Limited Export Docetaxel?

Who Are the Top Buyers of Docetaxel from Fresenius Kabi Oncology Limited?

What Is India's Total Docetaxel Export Value and How Much Does Fresenius Kabi Oncology Limited Contribute?

What Is the Average Shipment Value for Fresenius Kabi Oncology Limited's Docetaxel Exports?

How Does Fresenius Kabi Oncology Limited Compare to Other Indian Docetaxel Exporters?

What Docetaxel Formulations Does Fresenius Kabi Oncology Limited Export?

Regulatory Requirements: Exporting Docetaxel to Key Markets

Germany — BfArM/EMA

How Does Fresenius Kabi Oncology Limited Compare to Nearest Docetaxel Exporters?

Which Indian Ports Ship Docetaxel Exports?

What Other Oncology Products Does Fresenius Kabi Oncology Limited Export?

Geopolitical & Trade Policy Impact on Fresenius Kabi Oncology Limited's Docetaxel Exports

Fresenius Kabi Oncology Limited — Regulatory Compliance & Quality Standards

About Fresenius Kabi Oncology Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Docetaxel Export Data from Fresenius Kabi Oncology Limited

Docetaxel Stats

Company Overview

Top Products by Fresenius Kabi Oncology Limited

Related Analysis

Need Detailed Export Data?

Data Source